BMRN
Price
$61.53
Change
+$0.28 (+0.46%)
Updated
Jan 17 closing price
Capitalization
11.73B
32 days until earnings call
TRRI
Price
$0.20
Change
-$0.00 (-0.00%)
Updated
Jan 10 closing price
Capitalization
298.04K
Ad is loading...

BMRN vs TRRI

Header iconBMRN vs TRRI Comparison
Open Charts BMRN vs TRRIBanner chart's image
BioMarin Pharmaceutical
Price$61.53
Change+$0.28 (+0.46%)
Volume$2.64M
Capitalization11.73B
Trinity Resources
Price$0.20
Change-$0.00 (-0.00%)
Volume$267
Capitalization298.04K
BMRN vs TRRI Comparison Chart
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. TRRI commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Hold and TRRI is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (BMRN: $61.53 vs. TRRI: $0.20)
Brand notoriety: BMRN and TRRI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 174% vs. TRRI: 21%
Market capitalization -- BMRN: $11.73B vs. TRRI: $298.04K
BMRN [@Biotechnology] is valued at $11.73B. TRRI’s [@Biotechnology] market capitalization is $298.04K. The market cap for tickers in the [@Biotechnology] industry ranges from $352.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileTRRI’s FA Score has 1 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • TRRI’s FA Score: 1 green, 4 red.
According to our system of comparison, TRRI is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 4 TA indicator(s) are bullish.

  • BMRN’s TA Score: 4 bullish, 5 bearish.

Price Growth

BMRN (@Biotechnology) experienced а -8.68% price change this week, while TRRI (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

BMRN is expected to report earnings on Apr 23, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($11.7B) has a higher market cap than TRRI($298K). TRRI YTD gains are higher at: 0.000 vs. BMRN (-6.390).
BMRNTRRIBMRN / TRRI
Capitalization11.7B298K3,926,174%
EBITDA507MN/A-
Gain YTD-6.3900.000-
P/E Ratio37.07N/A-
Revenue2.75BN/A-
Total Cash930MN/A-
Total Debt603MN/A-
FUNDAMENTALS RATINGS
BMRN vs TRRI: Fundamental Ratings
BMRN
TRRI
OUTLOOK RATING
1..100
7131
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
81100
PRICE GROWTH RATING
1..100
8437
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRRI's Valuation (4) in the null industry is significantly better than the same rating for BMRN (72) in the Biotechnology industry. This means that TRRI’s stock grew significantly faster than BMRN’s over the last 12 months.

TRRI's Profit vs Risk Rating (100) in the null industry is in the same range as BMRN (100) in the Biotechnology industry. This means that TRRI’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's SMR Rating (81) in the Biotechnology industry is in the same range as TRRI (100) in the null industry. This means that BMRN’s stock grew similarly to TRRI’s over the last 12 months.

TRRI's Price Growth Rating (37) in the null industry is somewhat better than the same rating for BMRN (84) in the Biotechnology industry. This means that TRRI’s stock grew somewhat faster than BMRN’s over the last 12 months.

BMRN's P/E Growth Rating (98) in the Biotechnology industry is in the same range as TRRI (100) in the null industry. This means that BMRN’s stock grew similarly to TRRI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRN
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
70%
Momentum
ODDS (%)
Bearish Trend 5 days ago
66%
MACD
ODDS (%)
Bearish Trend 5 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
64%
Advances
ODDS (%)
Bullish Trend 11 days ago
62%
Declines
ODDS (%)
Bearish Trend 5 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
63%
Aroon
ODDS (%)
Bullish Trend 5 days ago
58%
View a ticker or compare two or three
Ad is loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
BTC.X104408.070000-53.968750
-0.05%
Bitcoin cryptocurrency
GME27.51-0.21
-0.76%
GameStop Corp

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with IBO. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then IBO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
+0.46%
IBO - BMRN
60%
Loosely correlated
-3.11%
ITOS - BMRN
39%
Loosely correlated
+3.36%
FULC - BMRN
35%
Loosely correlated
-0.50%
PRME - BMRN
32%
Poorly correlated
+0.70%
RCUS - BMRN
31%
Poorly correlated
-0.64%
More

TRRI and

Correlation & Price change

A.I.dvisor tells us that TRRI and RLFTF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TRRI and RLFTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRRI
1D Price
Change %
TRRI100%
N/A
RLFTF - TRRI
26%
Poorly correlated
+1.87%
BMRN - TRRI
26%
Poorly correlated
+0.46%
VANI - TRRI
24%
Poorly correlated
-0.83%
SPRB - TRRI
22%
Poorly correlated
-4.75%
LENZ - TRRI
22%
Poorly correlated
+0.45%
More